Mainz

• Phase 3 Study of Ravulizumab versus Placebo in Adult Participants at High Risk of DGF after Kidney Transplantation (AWAKE) Recruiting
  2024-517568-48-00 5 2025-07-21 Delayed Graft Function after Kidney Transplantation
• AZALOX Study: Safety and Efficacy of PXS-5505 with 5-Azacitidine in MDS and CMML Patients Recruiting
  2024-517237-40-00 8 2025-07-03 Myelodysplastic Neoplasms (MDS) and Chronic Myelomonocytic Leukemia (C
• A 12-week randomized, participant and investigator blinded, placebo-controlled, exploratory study in adult participants with Chronic Urticar … Recruiting
  2024-516355-41-00 4 2025-06-30 Chronic Inducible urticaria and Chronic Spontaneous Urticaria
• A Phase 2b Study to Assess the Efficacy and Safety of IMVT-1402 in Patients with Grave’s Disease Recruiting
  2024-516020-33-00 4 2025-06-26 Grave’s Disease
• Pembrolizumab in combination with lenvatinib in patients with recurrent, persistent, metastatic or locally advanced vulvar cancer not amenab … Recruiting
  2024-515646-16-00 4 2025-06-24 Recurrent, persistent, metastatic or locally advanced vulvar cancer
• Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction Recruiting
  2024-519219-32-00 5 2025-06-23 Heart Failure With Reduced Ejection Fraction
• A study to assess safety, cellular kinetics and exploratory efficacy of rapcabtagene autoleucel in rheumatoid arthritis and Sjogren’s diseas … Recruiting
  2024-514596-18-00 9 2025-06-20 Difficult to treat rheumatoid arthritis
• Safety, efficacy, and pharmacokinetics of BNT327 in combination with chemotherapy and other investigational agents for lung cancer Recruiting
  2024-515764-31-00 10 2025-06-13 Non-small cell lung cancer
• A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of PF-07275315 and PF-07264660 in Adult … Recruiting
  2023-505218-68-00 4 2025-06-12 Moderate-Severe Atopic Dermatitis
• A Phase I/II study of GSK5733584 in combination with anti-cancer therapies for advanced solid tumors Recruiting
  2024-517147-31-00 9 2025-05-23 Tumours, Gynecological
• A study Investigating Subcutaneously Administered Pozelimab in Combination with Cemdisiran or Cemdisiran Alone in Adult Participants with Ge … Recruiting
  2023-509547-27-00 5 2025-05-22 Geographic Atrophy Secondary to Age-Related Macular Degeneration
• A clinical study of V940 and pembrolizumab to treat lung cancer (V940-009) Recruiting
  2023-506327-29-00 5 2025-05-14 Non-Small Cell Lung Cancer
• A study with three treatments for higher-risk chronic myelomonocytic leukaemia. Recruiting
  2024-511102-22-00 4 2025-05-13 chronic myelomonocytic Leukemia
• Study of lunsekimig (SAR443765) compared with placebo in adults with high-risk asthma Recruiting
  2024-513959-33-00 4 2025-05-13 Asthma
• A trial to learn how well baxdrostat with dapagliflozin works compared to dapagliflozin on clinical outcomes alone and how safe it is in adu … Recruiting
  2023-506460-14-00 5 2025-05-07 Chronic kidney disease (CKD) and hypertension.
• A clinical trial to evaluate the safety and the efficacy of NEXAGON ® (Lufepirsen Ophthalmic Gel) in subjects with Persistent Corneal Epithe … Recruiting
  2023-507030-24-00 4 2025-04-30 Persistent Corneal Epithelial Defects
• Is CT 01 safe to use alone or combined with Everolimus for inoperable advanced liver cancer? Recruiting
  2024-511435-10-00 1 2025-04-30 Hepatocellular Carcinoma
• Phase 3 study of belantamab mafodotin, lenalidomide, and dexamethasone (BRd) versus daratumumab, lenalidomide, and dexamethasone (DRd) in pa … Recruiting
  2024-516030-35-00 5 2025-04-30 Multiple myeloma
• Randomized, double-blind, placebo-controlled Phase I study in healthy individuals on autotaxin-inhibition with MJK2134025 in single-ascendin … Recruiting
  2024-513116-10-00 1 2025-03-31 Stroke
• Reduction of occurence of Acute Kidney Injury through administration of angiotensin II versus Noradrenaline Recruiting
  2024-517771-21-00 11 2025-03-31 Acute kidney injury
• Efficacy of Venetoclax in combination with Rituximab in Waldenström’s Macroglobulinemia Recruiting
  2022-500574-34-00 4 2025-03-21 Waldenström’s Macroglobulinemia
• Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant Recruiting
  2024-513547-82-00 5 2025-03-11 Transthyretin Amyloidosis
• A trial to learn if AZD0486 alone or with other anticancer drugs is safe and works in adults with certain blood cancers Recruiting
  2024-515034-33-00 9 2025-03-05 Mantle Cell Lymphoma
• A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Axatilimab (INCA034176) and Corticosteroids as Initial Treatment for Chroni … Recruiting
  2023-510292-65-00 5 2025-02-25 chronic graft-versus-host disease

Showing 169–192 of 589 trials